In a regulatory filing, Elanco (ELAN) disclosed that its director David Hoover bought 25K shares of common stock on March 5th in a total transaction size of $272.6K. See what stocks are receiving ...

Elanco Animal Health (NYSE:ELAN) traded lower in the premarket on Tuesday after the veterinary product maker, with its Q4 2024 results, set its full-year outlook below consensus, citing an ...

Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for. Elanco missed analysts’ revenue expectations by 0.6% last ...

Animal health company Elanco (NYSE:ELAN) reported Q4 CY2024 results exceeding the market’s revenue expectations , but sales fell by 1.4% year on year to $1.02 billion. On the other hand, ...

In this article, we are going to take a look at where Elanco Animal Health Incorporated (NYSE:ELAN) stands against the other stocks. Ten firms ended Tuesday suffering a sell-off, as investor ...

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as ...

As of December 31, 2024, Elanco's net leverage ratio was 4.3x adjusted EBITDA, flat to September 30, 2024. The company anticipates a headwind to revenue of approximately $110 million from the ...